BLAUVELT, A. .; CONRAD, C. .; COSTANZO, A. .; VAN DE KERKHOF, P. .; HAN, G. .; LANGLEY, R. G. .; DAVIS, L. .; HOEPKEN, B. .; WIEGRATZ, S. .; PUIG, L. . Bimekizumab Continuous Maintenance of Eesponse at Every Visit Through Two Years in Patients with Moderate to Severe Plaque Psoriasis: Post-hoc Results from Five Phase 3/3b Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 1, p. s303, 2024. DOI: 10.25251/skin.8.supp.303. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2436. Acesso em: 3 jul. 2024.